Qaialdo 10 mg / ml oral suspension

Licence status
Authorised: 26/05/2023
Active substances
Spironolactone
Dosage Form
Oral suspension
Licence number
EU/1/23/1731/001
Licence holder
Nova Laboratories Ireland Limited

Product documents

Licence information

ATC code
C03DA01 spironolactone
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
26/05/2023